Has carbohydrate-restriction been forgotten as a treatment for diabetes mellitus? A perspective on the ACCORD study design

Nutrition and Metabolism

Volumn 5, Issue 1, 2008, Pages

  Westman, Eric C ^a   Vernon, Mary C ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE;

CARBOHYDRATE INTOLERANCE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DIABETES MELLITUS; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; LOW CARBOHYDRATE DIET; MEDICAL RESEARCH; MORTALITY; NOTE; PATHOPHYSIOLOGY;

EID: 42249087794     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-5-10     Document Type: Note

References (15)

1. Total dietary regulation in the treatment of diabetes. Monograph No. 11. FM Allen E Stillman R Fitz, New York: Rockefellar Institute for Medical Research 1919
2. A diabetic manual for the mutual use of doctor and patient. EP Joslin, Philadelphia: Lea & Febiger 1919
3. W Osler T McCrae, The principles and practice of medicine New York: D. Appleton 9 1923
4. ACCORD Blood Sugar Treatment Strategy Announcement. National Heart Lung and Blood Institute, February 6, 2008
5. Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods. The ACCORD Study Group, Am J Cardiol 2007 99 21i 33i 17599422
6. Diabetes Control and Complications Trial (DCCT), N Engl J Med 1993 329 977 986 10.1056/NEJM199309303291401 8366922
7. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women. The A to Z weight loss study: A randomized trial. CD Gardner A Kiazand S Alhassan RS Stafford RR Balise HC Kraemer AC King, JAMA 2007 297 969 977 10.1001/jama.297.9.969 17341711
8. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. ML Dansinger JA Gleason JL Griffith HP Selker EJ Schaefer, JAMA 2005 293 43 53 10.1001/jama.293.1.43 15632335
9. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. RM Krauss PJ Blanche RS Rawlings HS Fernstrom PT Williams, Am J Clin Nutr 2006 83 1025 31 16685042
10. Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. JS Volek RD Feinman, Nutr Metab (Lond) 2005 16:2 31 10.1186/1743-7075-2-31
11. Clinical experience of a carbohydrate-restricted diet: effect on diabetes mellitus. MC Vernon J Mavropoulos M Transue WS Yancy Jr EC Westman, Metabolic Syndrome and Related Disorders 2003 1 233 237 10.1089/154041903322716714
12. The effects of a low-carbohydrate regimen on glycemic control and serum lipids in diabetes mellitus. DF O'Neill EC Westman RK Bernstein, Metabolic Syndrome and Related Disorders 2003 1 291 298 10.1089/1540419031361345
13. Clinical use of a carbohydrate-restricted diet to treat the dyslipidemia of the metabolic syndrome. JT Hickey L Hickey WS Yancy Jr J Hepburn EC Westman, Metabolic Syndrome and Related Disorders 2003 1 227 232 10.1089/ 154041903322716705
14. A pilot trial of a low-carbohydrate, ketogenic diet in patients with Type 2 Diabetes. WS Yancy Jr MC Vernon EC Westman, Metabolic Syndrome and Related Disorders 2003 1 239 243 10.1089/154041903322716723
15. Low-carbohydrate nutrition and metabolism. EC Westman RD Feinman JC Mavropoulos MC Vernon JS Volek JA Wortman WS Yancy Jr SD Phinney, Am J Clin Nutr 2007 86 276 84 17684196